Research Paper Volume 13, Issue 1 pp 450—459
Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in BRCA-mutated HER2-negative metastatic or advanced breast cancer: a network meta-analysis
Figure 2. Representation of potential bias in the included RCTs.